Melatonin Directly Binds and Inhibits Death-Associated Protein Kinase 1 Function in Alzheimer's Disease.

Death-associated protein kinase 1 (DAPK1) is upregulated in the brains of human Alzheimer's disease (AD) patients compared with normal subjects, and aberrant DAPK1 regulation is implicated in the development of AD. However, little is known about whether and how DAPK1 function is regulated in AD. Here, we identified melatonin as a critical regulator of DAPK1 levels and function. Melatonin significantly decreases DAPK1 expression in a post-transcriptional manner in neuronal cell lines and mouse primary cortical neurons. Moreover, melatonin directly binds to DAPK1 and promotes its ubiquitination, resulting in increased DAPK1 protein degradation through a proteasome-dependent pathway. Furthermore, in tau-overexpressing mouse brain slices, melatonin treatment and the inhibition of DAPK1 kinase activity synergistically decrease tau phosphorylation at multiple sites related to AD. In addition, melatonin and DAPK1 inhibitor dramatically accelerate neurite outgrowth and increase the assembly of microtubules. Mechanistically, melatonin-mediated DAPK1 degradation increases the activity of Pin1, a prolyl isomerase known to play a protective role against tau hyperphosphorylation and tau-related pathologies. Finally, elevated DAPK1 expression shows a strong correlation with the decrease in melatonin levels in human AD brains. Combined, these results suggest that DAPK1 regulation by melatonin is a novel mechanism that control tau phosphorylation and function and offers new therapeutic options for treating human AD.

[1]  R. Reiter,et al.  Identification of a novel melatonin‐binding nuclear receptor: Vitamin D receptor , 2019, Journal of Pineal Research.

[2]  U. K. Marelli,et al.  Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments. , 2019, Biochimica et biophysica acta. General subjects.

[3]  P. Negredo,et al.  Pharmacological doses of melatonin impede cognitive decline in tau‐related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux , 2019, Journal of pineal research.

[4]  Xiao Zhen Zhou,et al.  Death-Associated Protein Kinase 1 Phosphorylation in Neuronal Cell Death and Neurodegenerative Disease , 2019, International journal of molecular sciences.

[5]  Md. Farhad Hossain,et al.  Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology , 2019, Molecular Neurobiology.

[6]  Xiao Zhen Zhou,et al.  Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease , 2019, Recent patents on anti-cancer drug discovery.

[7]  N. Ito,et al.  The trans isomer of Tau peptide is prone to aggregate, and the WW domain of Pin1 drastically decreases its aggregation , 2018, FEBS letters.

[8]  P. Govitrapong,et al.  Melatonin ameliorates Aβ42‐induced alteration of βAPP‐processing secretases via the melatonin receptor through the Pin1/GSK3β/NF‐κB pathway in SH‐SY5Y cells , 2018, Journal of pineal research.

[9]  R. Reiter,et al.  Mechanisms of Melatonin in Alleviating Alzheimer’s Disease , 2017, Current neuropharmacology.

[10]  L. Cantley,et al.  Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death , 2016, Cell Death and Differentiation.

[11]  Yangling Mu,et al.  Selective Degeneration of Entorhinal-CA1 Synapses in Alzheimer's Disease via Activation of DAPK1 , 2016, The Journal of Neuroscience.

[12]  R. Tanzi,et al.  Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein. , 2016, Human molecular genetics.

[13]  M. Kim,et al.  Melatonin ameliorates amyloid beta‐induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus , 2015, Journal of pineal research.

[14]  Shan Wang,et al.  A Novel Mechanism of Spine Damages in Stroke via DAPK1 and Tau , 2015, Cerebral cortex.

[15]  G. Buonocore,et al.  Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia–ischemia , 2014, Journal of pineal research.

[16]  A. Kimchi,et al.  Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function , 2014, Cell Death and Disease.

[17]  L. Welberg.  Circadian rhythms: Methylation mediates clock plasticity , 2014, Nature Reviews Neuroscience.

[18]  P. Gallagher,et al.  Post-translational regulation of the cellular levels of DAPK , 2014, Apoptosis.

[19]  A. Kimchi,et al.  The DAPK family: a structure–function analysis , 2014, Apoptosis.

[20]  T. Yamashita,et al.  Role of DAPK in neuronal cell death , 2014, Apoptosis.

[21]  Q. Tian,et al.  Melatonin in Alzheimer’s Disease , 2013, International journal of molecular sciences.

[22]  Cornelia M. Wilson,et al.  Tau protein kinases: Involvement in Alzheimer's disease , 2013, Ageing Research Reviews.

[23]  S. Overeem,et al.  Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: Focus on the role of hypocretin and melatonin , 2013, Ageing Research Reviews.

[24]  L. Fuentes-Broto,et al.  Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin , 2012, Journal of pineal research.

[25]  C. Chien,et al.  DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity , 2011, Cell Death and Differentiation.

[26]  Robert W Buzzeo,et al.  Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling , 2011, Journal of pineal research.

[27]  K. Lu,et al.  Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease , 2011, Expert Reviews in Molecular Medicine.

[28]  A. Goate,et al.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. , 2011, Molecular cell.

[29]  H. Shih,et al.  The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses , 2010, The EMBO journal.

[30]  M. M. Soundarapandian,et al.  DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke , 2010, Cell.

[31]  Kazuhiro Ishida,et al.  Identification of death-associated protein kinases inhibitors using structure-based virtual screening. , 2009, Journal of medicinal chemistry.

[32]  S. Dudek,et al.  TNF-α preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein , 2009, The Journal of Immunology.

[33]  P. Davies,et al.  Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology , 2009, The Journal of Neuroscience.

[34]  S. Dudek,et al.  TNF-α Preconditioning Protects Neurons via Neuron-Specific Up-Regulation of CREB-Binding Protein1 , 2009, The Journal of Immunology.

[35]  Bradley T. Hyman,et al.  Tau pathophysiology in neurodegeneration: a tangled issue , 2009, Trends in Neurosciences.

[36]  Nava Zisapel,et al.  Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways , 2008, Progress in Neurobiology.

[37]  Y. Liou,et al.  Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy. , 2008, The Journal of clinical investigation.

[38]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[39]  P. Gallagher,et al.  Regulation of Death-associated Protein Kinase , 2007, Journal of Biological Chemistry.

[40]  K. Leroy,et al.  Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration , 2007, Neuropathology and applied neurobiology.

[41]  P. Gallagher,et al.  Control of Death-associated Protein Kinase (DAPK) Activity by Phosphorylation and Proteasomal Degradation* , 2006, Journal of Biological Chemistry.

[42]  L. Mucke,et al.  100 Years and Counting: Prospects for Defeating Alzheimer's Disease , 2006, Science.

[43]  M. Pallàs,et al.  The role of CDK5/P25 formation/inhibition in neurodegeneration. , 2006, Drug news & perspectives.

[44]  Jian-Guo Chen,et al.  Melatonin arrests peroxynitrite‐induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain , 2006, Journal of pineal research.

[45]  Taylor J. Maxwell,et al.  DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. , 2006, Human molecular genetics.

[46]  A. Kimchi,et al.  The death-associated protein kinases: structure, function, and beyond. , 2006, Annual review of biochemistry.

[47]  S. Akira,et al.  Deletion of the kinase domain from death-associated protein kinase enhances spatial memory in mice. , 2006, International journal of molecular medicine.

[48]  C. Ekmekcioglu.  Melatonin receptors in humans: biological role and clinical relevance. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  M. Shamloo,et al.  Death-associated Protein Kinase Is Activated by Dephosphorylation in Response to Cerebral Ischemia* , 2005, Journal of Biological Chemistry.

[50]  D. Swaab,et al.  The human pineal gland and melatonin in aging and Alzheimer's disease , 2005, Journal of pineal research.

[51]  G. Johnson,et al.  Tau phosphorylation: physiological and pathological consequences. , 2005, Biochimica et biophysica acta.

[52]  G. Johnson,et al.  Tau phosphorylation in neuronal cell function and dysfunction , 2004, Journal of Cell Science.

[53]  Jian-Zhi Wang,et al.  Effect of inhibiting melatonin biosynthesis on spatial memory retention and tau phosphorylation in rat , 2004 .

[54]  Jian-Zhi Wang,et al.  Melatonin attenuates isoproterenol‐induced protein kinase A overactivation and tau hyperphosphorylation in rat brain , 2004, Journal of pineal research.

[55]  Anthony Holland,et al.  Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain , 2004, The European journal of neuroscience.

[56]  Jian-Zhi Wang,et al.  Melatonin protects SH‐SY5Y neuroblastoma cells from calyculin A‐induced neurofilament impairment and neurotoxicity , 2004, Journal of pineal research.

[57]  R. Ravid,et al.  Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. , 2003, The Journal of clinical endocrinology and metabolism.

[58]  W. Kamphorst,et al.  Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels , 2003, Journal of pineal research.

[59]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[60]  Tony Hunter,et al.  Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.

[61]  R. Cheung.  The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion , 2003, Journal of pineal research.

[62]  D. Acuña-Castroviejo,et al.  Calreticulin-melatonin. An unexpected relationship. , 2003, European journal of biochemistry.

[63]  H. Braak,et al.  Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. , 2002, Brain research. Molecular brain research.

[64]  P. Gallagher,et al.  A Death-associated Protein Kinase (DAPK)-interacting Protein, DIP-1, Is an E3 Ubiquitin Ligase That Promotes Tumor Necrosis Factor-induced Apoptosis and Regulates the Cellular Levels of DAPK* , 2002, The Journal of Biological Chemistry.

[65]  I. Kanazawa,et al.  JNK activation is associated with intracellular β-amyloid accumulation , 2000 .

[66]  E. Ferrari,et al.  Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia , 2000, Experimental Gerontology.

[67]  Li-Huei Tsai,et al.  NUDEL Is a Novel Cdk5 Substrate that Associates with LIS1 and Cytoplasmic Dynein , 2000, Neuron.

[68]  Hiroshi Takahashi,et al.  Developmental changes in distribution of death‐associated protein kinase mRNAs , 1999, Journal of neuroscience research.

[69]  N. Holbrook,et al.  Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. , 1999, Neuroreport.

[70]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[71]  W. Markesbery,et al.  p38 Kinase Is Activated in the Alzheimer's Disease Brain , 1999, Journal of neurochemistry.

[72]  Yasuo Hishikawa,et al.  Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep–waking , 1999, Biological Psychiatry.

[73]  M. Goedert,et al.  Tau protein pathology in neurodegenerative diseases , 1998, Trends in Neurosciences.

[74]  K. Ohara,et al.  Daily rhythm of serum melatonin in patients with dementia of the degenerate type , 1996, Brain Research.

[75]  I. Grundke‐Iqbal,et al.  Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation , 1994, FEBS letters.

[76]  J. McCarty,et al.  Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. , 1994, Journal of cell science.

[77]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[78]  D. F. Swaab,et al.  Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease , 1990, Brain Research.

[79]  R. Neve,et al.  The microtubule binding domain of tau protein , 1989, Neuron.

[80]  E. Shooter,et al.  Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors , 1985, The Journal of cell biology.

[81]  S. Chinnathambi,et al.  Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[82]  Xiang-Shu Cheng,et al.  Phosphorylation of tau by death-associated protein kinase 1 antagonizes the kinase-induced cell apoptosis. , 2013, Journal of Alzheimer's disease : JAD.

[83]  Q. Tian,et al.  Constant illumination induces Alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin. , 2009, Journal of Alzheimer's disease : JAD.

[84]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[85]  I. Kanazawa,et al.  JNK activation is associated with intracellular beta-amyloid accumulation. , 2000, Brain research. Molecular brain research.

[86]  D F Swaab,et al.  Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. , 1999, The Journal of clinical endocrinology and metabolism.

[87]  J. Mandell,et al.  Microtubule-associated proteins, phosphorylation gradients, and the establishment of neuronal polarity. , 1996, Perspectives on developmental neurobiology.